Sep 2, 2026 earnings call — AccessOne and Provider Connect expansion
Maintained fiscal 2027 revenue outlook of $510 million to $520 million.
Revenue $0.1B (est $0.1B) · EPS $0.03 (est $0.09) · Next-quarter revenue outlook $0.5B–$0.5B
Key quotes
"The revenue range provided for fiscal 2027 assumes approximately $37 million of contribution from AccessOne and no additional revenue from potential future acquisitions completed between now and January 31, 2027."
"In the GLP-1 category, a 4-month study showed a 4% incremental lift in new-to-brand prescriptions versus a matched control group and more than 1,000 new patient starts."
"We generated positive operating and free cash flow again this quarter, which together with available cash, allowed us to reduce debt principal by over $23 million while maintaining a healthy cash balance."
Analyst Q&A 11
AccessOne sales restart
Q (Sean Dodge · BMO): How is selling AccessOne into non-investment-grade clients going? How is the AccessOne selling motion being restarted?
A: Management said they feel very good about the acquisition and progress since closing. They said the work is now on go-to-market and product fit and that they are having lots of conversations. They also said they are seeing early wins and positive client feedback and view it as a growth lever over the next couple of years.
"And hopefully, in the next couple of quarters, we'll be talking about this a lot more, but we are starting to see wins in the market, and we're really excited." — Chaim Indig (CEO)
Network Solutions visibility
Q (Cameron Harbilas · Jefferies): What are you seeing in Network Solutions and has visibility improved in the areas you called out earlier?
A: They said total revenue is largely the same from a top-line view. Underneath that, they report a lot of progress in business activity for the second half in Network Solutions. They also said new products like Provider Connect are resonating and they are encouraged versus 90 or 180 days ago.
"Underneath, we have seen a lot of progress on the second half in Network Solutions." — Balaji Gandhi (CFO)
GLP-1 pilot results
Q (Stanislav Berenshteyn · Wells Fargo): How did the GLP-1 campaign pilot perform and did it lead to any contract conversions or expanded opportunities?
A: They confirmed the pilot performed well and helped convert some new business. They said this result ties back to their earlier comments about improving activity in Network Solutions.
"And yes, we did mention that in our letter, and it did -- the answer is yes, it did help convert some new business activity and relates to the prior question, too." — Balaji Gandhi (CFO)
EHR competition and AHSC sales
Q (Jessica Tassan · Piper Sandler): How are you selling into AHSCs when EHRs offer competing check-in solutions? Are new AHSC sales happening where the EHR has no check-in product?
A: They said this competitive dynamic is normal and long-standing for the company. They said there is nothing new to report and that competitors are all present in the space. They also said they differentiate by product and go-to-market and that the team is doing a great job with happy clients.
"So there's really nothing new to call out, but they are all competitive with us, and that's just the nature of the space." — Balaji Gandhi (CFO)
Provider Connect traction
Q (Scott Schoenhaus · KeyBanc): Was Network Solutions strength driven by Provider Connect? Any change between budgets for Provider Connect and legacy D2C?
A: They said the team has had nice wins as the year progressed and did an excellent job. They pointed out that adding more provider-side footprint supports the team's success and that momentum continues. They did not call out a specific budget shift between the two but tied Provider Connect traction to broader provider footprint growth.
"And I think you just point out the aspect of our business model, part of the reason the team is able to do an excellent job is because we're also adding more footprint on the provider side." — Balaji Gandhi (CFO)
Subscription pricing and modeling
Q (Daniel Grosslight · Citi): How should we think about subscription pricing and should we model subscription revenue as flat in 3Q and 4Q?
A: They said providers face significant strain and the company aims to be a strong partner during this environment. Management said they are focused on total revenue and maintaining revenue overall. They added that if some second-half revenue shifts out of subscription and Network Solutions clarity increases, modelers could adjust, but total revenue guidance is unchanged.
"I think if you just sort of listen to the commentary here, we're maintaining our revenue" — Balaji Gandhi (CFO)
R&D and revenue cycle expansion
Q (Ryan MacDonald · Needham): How are you investing in provider products and might you expand into prior authorization and monetize it?
A: They said the front-end revenue cycle has room for continuous improvement and they will keep helping clients there. They said they will not comment on specific new products now, but they are doubling down on building tools that help providers and patients. They also said AccessOne is an extension of this strategy.
"So we are doubling down and continuing our commitment in providing phenomenal tools to providers that help them help their patients." — Chaim Indig (CEO)
AI in payments and products
Q (Richard Close · Canaccord Genuity): How are you thinking about adding AI to payments and patient engagement?
A: They said they are embracing AI across the organization and it has had meaningful impact on product, operations, selling, and support. They gave examples like voice AI and Plan Match automating tasks that were previously human in the loop. They said AI lets them test ideas faster and scale what works, and it increases their excitement about future opportunities.
"There's things like Plan Match that allow them to do things that were just human in the loop before we're automating how they understand and pick the right plan." — Chaim Indig (CEO)
EBITDA guidance rationale
Q (Truist): Why did you keep EBITDA guidance the same? Is it due to Network Solutions revenue mix or other factors?
A: They said it is a mix of factors. Management praised the team's discipline on expense management and return on investment and said they want room to invest for growth. They also called out revenue mix sensitivity and the early innings of AI deployment as reasons for prudence.
"I think that we have been -- our team has done an excellent job and been very disciplined about expense management and around return on investment." — Balaji Gandhi (CFO)
Retention, attach rates, revenue mix
Q (Destiny Ann Jackson · JPMorgan): As you lower subscription pricing to drive payments and network growth, how are retention and attach rates changing and how will revenue per client mix shift long-term?
A: They said they think about total revenue holistically and will continue to communicate on total revenue per client. They said the mix will fluctuate over time and that fluctuation is acceptable and shows business diversity. They did not give specific retention or attach-rate numbers.
"What we'd say there is we holistically think about total revenue." — Balaji Gandhi (CFO)
Patient volume and deductible trends
Q (Ryan Halsted · RBC): Any color on patient volume trends for Payment Solutions and pace of patients moving through deductibles into the back half?
A: They said they review the data carefully and do a lot of trending. They noted earlier commentary of a little more weakness beyond seasonality earlier in the year but said there was nothing notable to call out in the second quarter on volume or deductible reset trends. So they said there is nothing specific to report for Q2.
"I mean I think we look at all this data very carefully and do a lot of trending." — Balaji Gandhi (CFO)